Adenomyosis uteri: an update

In: The Obstetrician & Gynaecologist · 2009 · vol. 11(1) , pp. 41–47 · doi:10.1576/toag.11.1.41.27467 · W2076965778
article OA: closed CC0 ⤵ 19 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This review updates knowledge on adenomyosis uteri, discussing its definition, association with other pathologies, surgical treatments, diagnostic considerations, and ethical issues for women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Adenomyosis uteri is defined by the presence of endometrium in the myometrium. The prevalence in asymptomatic women remains unknown. It is commonly associated with other pathologies. Hysterectomy remains the main surgical option for women whose families are complete. Learning objectives: To understand the theories regarding the aetiology. To appreciate the clinical picture and complications. To learn about current treatment modalities. Ethical issues: Counselling women with adenomyosis uteri is challenging when the clinical significance of the condition is uncertain. Are more expensive diagnostic tests, such as magnetic resonance imaging, justifiable? Is the risk–benefit weighted against invasive investigation? Please cite this article as: Mehasseb MK and Habiba MA. Adenomyosis uteri: an update. The Obstetrician & Gynaecologist 2009;11:41–47.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (58)

Cited by (19)

Source provenance

openalex
last seen: 2026-06-10T16:23:13.998983+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK